In recent decades, significant progress has been made in the diagnosis and management of congenitally corrected transposition of the great arteries (ccTGA). Nevertheless, gradual dysfunction and failure of the right ventricle (RV) in the systemic circulation remain the main contributors to mortality and disability for patients with ccTGA, especially after adolescence. Anatomic repair of ccTGA effectively resolves the problem of failure of the systemic RV and has good early and midterm results. However, this strategy is applicable primarily in infants and children up to their teens and has associated risks and limitations, and new challenges can arise in the late postoperative period. Patients with ccTGA manifesting progressive systemic RV dysfunction beyond adolescence represent the major challenge. Several palliative options such as cardiac resynchronization therapy, tricuspid valve repair or replacement, pulmonary artery banding, and implantation of an assist device into the systemic RV can be used to improve functional status and to delay the progression of ventricular dysfunction in patients who are not suitable for anatomic correction of ccTGA. For adult patients with severe systemic RV failure, heart transplantation currently remains the only longterm lifesaving procedure, although donor organ availability remains one of the most limiting factors in this type of therapy. This review focuses on current surgical and medical strategies and interventional options for the prevention and management of systemic RV failure in adults and children with ccTGA.
Management of Systemic Right Ventricular Failure in Patients With Congenitally Corrected
Transposition of the Great Arteries C ongenitally corrected transposition of the great arteries (ccTGA) is a rare but well-described congenital cardiac malformation with an incidence of ≈1 in 33 000 live births (0.5% of all patients with congenital heart defects). Morphologically, ccTGA comprises a combination of atrioventricular and ventricular-arterial discordance ("double discordance"). 1 In up to 80% of cases, ccTGA is accompanied by associated cardiac lesions: ventricular septal defects (VSDs) in 60% to 80% of cases, pulmonary stenosis in ≈50%, and abnormalities of the conduction system in 15% to 50%. 1 Patients with isolated ccTGA usually are asymptomatic early in life and can survive well into adulthood. However, in this scenario, the right ventricle (RV) and the tricuspid valve (TV) support systemic circulation for decades, which can lead to gradual dysfunction and failure of these structures. Therapeutic options for adult patients presenting with failing systemic RV are quite limited, and the number of these individuals will increase during the next decades, 2,3 making the development of an effective strategy for the management of these patients one of the more important unresolved problems.
RV In ThE SySTEMIC CIRCulATIon
In ccTGA, the RV presents as a systemic pumping chamber; therefore, its structural and morphological relationships and the interventricular interactions become abnormal. High systolic pressures inside the RV lead to eccentric hypertrophy of its free wall, shift of the interventricular septum toward the left ventricle (LV), and dilation of the RV, resulting in increased ventricular wall stress and dysfunction of the trabecular component, papillary muscles, and valvar apparatus of the RV. 4 
Coronary Arteries
The coronary arteries in ccTGA are inverted, arise from anterior and posterior aortic sinuses, and follow their respective ventricles. The systemic RV is supplied only by the left-sided (morphologically right) coronary artery, which can lead to inadequate perfusion of the hypertrophied ventricular mass and deterioration of the RV function with increasing age. Despite the significant increase in myocardial blood flow through the right coronary artery, hypertrophy of the RV is not supported by adequate proliferative response of the capillary vasculature. Coronary flow reserve is significantly decreased in patients with ccTGA even in the absence of ischemic symptoms, and global RV dysfunction is strongly correlated with attenuated maximal coronary blood flow. 5, 6 Radionuclide scanning indicated myocardial perfusion defects correlated with regional thickening and abnormal motion of the ventricular wall in adult and pediatric patients with ccTGA at the subclinical stage. 7 It is interesting to note that a more recent study did not find myocardial fibro-sis of the RV resulting from recurrent ischemia as a significant contributor to systemic RV failure, although the sensitivity of the imaging technique used may not allow detection of microscopic fibrosis. 8 Nevertheless, relative coronary insufficiency can play an important role in the development of late RV dysfunction and asymptomatic ischemia in older patients with ccTGA after the fourth decade of life.
Conduction System
The conduction system in ccTGA is distinctly abnormal because of the malalignment of the atrioventricular septum. The conduction system takes a longer course to the ventricles, which can be a reason for the occurrence of ventricular arrhythmias and complete heart block, especially with increasing age. 6 Dilation of the atrial chambers and abnormal shift of the atrioventricular septum over time are also given to be reasons for emergence of supraventricular arrhythmias and heart block in patients with ccTGA. 9, 10 
TV in the Systemic Circulation
Tricuspid regurgitation (TR) has been found to be a major contributor to the development of progressive RV dysfunction and failure in adult patients with ccTGA with a systemic RV. 4, 11, 12 In ccTGA, RV hypertrophy is followed by dilation, and the ventricular shape becomes more spherical. The tricuspid annulus dilates; papillary muscles move away from the inflow tract; and tethered cords do not allow the leaflets to occlude the orifice. These mechanisms predispose to the steady increase in TR over time.
Some patients with ccTGA have coexistent lesions of the TV. The most common one is an Ebstein-like thickening and shortening of the cords and, in some patients, apical displacement of the septal and mural leaflets. 1, 11 This group of patients is more likely to develop significant TR and ventricular dysfunction early in life. 2 
Associated Intracardiac lesions
A VSD and obstruction of the pulmonary valve are most commonly associated with ccTGA. The VSD is usually located beneath the pulmonary valve in the conoventricular region. Patients with large VSDs present with left-to-right shunt resulting in pulmonary overflow early in infancy.
Obstruction of the pulmonary outflow tract occurs in ≈50% of cases. In ccTGA, the pulmonary artery (PA) is positioned deep inside the crux of the heart, between the mitral valve and TV, and this location predisposes it to subvalvar obstruction. The pulmonary outflow tract can be obstructed by accessory fibrous tissue from the septum and mitral valve or by the accessory tissue around the VSD. 1 
ClInICAl PRESEnTATIon And ASSESSMEnT oF SySTEMIC RV FunCTIon
Clinical symptoms in infancy and early childhood depend on the presence and severity of associated intracardiac lesions. Complete heart block occurs in 10% to 15% of patients at birth, and its incidence increases over time, reaching >30% in adult patients.
Patients without significant associated intracardiac lesions usually do not have symptoms of heart failure in childhood and do well until adult life. However, the RV dysfunction progresses over time, as does TR. RV dysfunction usually remains subclinical for decades and typically manifests during fourth and fifth decades of life. 1 By 45 years of age, >30% of patients with isolated ccTGA and more than two thirds of patients with associated lesions develop clinical congestive heart failure. The mortality among 77 adult patients with ccTGA was reported by Dobson et al 12 as 16% at 40 years of age, and most deaths were caused by atrial tachyarrhythmia, sudden death, or congestive heart failure.
Adult patients with systemic RV can develop severe RV failure or fatal tachyarrhythmia unpredictably. Therefore, these patients require regular (every 6-8 months) followup, including echocardiography and a treadmill exercise test. Systemic RV dysfunction can be identified at the subclinical stage if sensitive measures of myocardial performance are used. 12, 13 Cardiac magnetic resonance and routine echocardiography imaging are useful in identifying subclinical RV dysfunction, especially if quantitative parameters (RV index of myocardial performance, tissue displacement, and strain) are calculated. The degree of TR might be underestimated by echocardiography in some patients; therefore, cardiac magnetic resonance should be used in patients with progressive TR to decide whether surgical intervention on the TV is necessary. Patients with systemic RV and a history of cardiac surgery in infancy have higher risk of adverse outcome (sudden death, RV failure, TR) and require special attention.
SuRGICAl MAnAGEMEnT oF ThE FAIlInG SySTEMIC RV In PATIEnTS WITh CCTGA
Surgical management of ccTGA implies 2 basic strategies. The strategy of physiological repair was introduced in the early 1960s. It involves repair of associated cardiac anomalies and surgical palliations to improve the patient's clinical presentation and prognosis. The RV remains the systemic pumping chamber in physiological repair. This strategy was widely used during 3 decades, but long-term follow-up demonstrated suboptimal outcomes in these patients. In the 1990s, physiological repair was replaced by a strategy of anatomic correction in most centers. However, many patients remain with a systemic RV with isolated ccTGA or with physi-ological repair only. The management options for those who present with RV dysfunction and failure are limited. Assessment should be made if they are candidates for anatomic repair or remain with a systemic RV, but associated lesions such as TR, complete heart block, or clinically important VSDs with associated pulmonary stenosis can be treated.
AnAToMIC REPAIR: SInGlE VERSuS STAGEd
In selected cases in which the ventricular dysfunction is confined to the RV and the LV has preserved systolic function, an anatomic repair can be considered. Except in cases in which the LV is at systemic pressures such as patients with a large VSD and pulmonary stenosis, an anatomic repair usually requires staged LV preparation to gain muscle mass before it can support the systemic circulation. In the former case in which the LV is at systemic pressures as a result of the VSD and pulmonary stenosis, proceeding directly to an anatomic repair with a Mustard/ Senning atrium-level switch plus a Rastelli-type LV to aortic tunnel and RV to PA conduit offers the best long-term option. 3, 14, 15 Unfortunately, these cases are rare.
More commonly, the LV requires preparation with a PA band to increase afterload in an effort to induce ventricular hypertrophy. This strategy is most successful early in life when somatic growth is still high. In older teens and adults, the ability of the LV to increase muscle mass without inducing fibrosis is very limited. Successful preparation of the LV is possible only in young infants and children <15 years of age, 3 with rare exceptions.
In a small number of adult patients who have high (close to systemic) LV pressures caused by coexistent nonrestrictive VSD or significant pulmonary stenosis, staged anatomic correction at a later age may be possible ( Figure 1 ). Cardiac magnetic resonance measurement of muscle mass and indexes of systolic function is very important, along with cardiac catheterization to measure end-diastolic pressure, before anatomic correction is considered in these patients.
PA Banding as a Palliative Procedure
The PA banding procedure in ccTGA can have 2 aims: preparation of the LV for anatomic repair and as a palliative procedure aimed at improving RV function by reducing TR and restoring normal geometric relationships between the RV, interventricular septum, TV, and subvalvar structures. The mechanism of PA banding in ccTGA with RV and TV dysfunction is thought be due to the fact that the PA band elevates the LV pressure, reduces leftward septal shift, prevents further tricuspid annular dilation, and therefore improves the stage of heart failure. 4 Some patients have significantly improved ventricular function with banding alone, and this approach can be used for prophylaxis and management of RV failure in patients with isolated ccTGA or as a palliative surgery in patients not suitable for anatomic correction. 16 Good intermediate results of this "openended" palliation in 15 pediatric patients with ccTGA were reported by the group from Leuven. 17 A recent clinical trial from our institution 18 reported results of PA banding for LV preparation in 25 pediatric patients, 18 of whom subsequently underwent anatomic repair. All 12 patients who were banded before 2 years of age had improved morphological RV function and were free of LV failure after PA banding, and 11 of them underwent anatomic repair and had preserved biventricular function. In comparison, 4 of 6 patients with PA banding performed after 2 years of age developed LV dysfunc-tion after banding. Early PA banding also resulted in favorable function of the neoaortic valve after anatomic correction. Older children and adolescents respond to PA banding by hypertrophy rather than hyperplasia; as a consequence, they may be more likely to develop rapid LV diastolic dysfunction. Impaired contraction and relaxation of the LV as a result of hypertrophy significantly compromise outcomes in this group, especially if patients are banded for a long period. 16 
Results of Anatomic Correction
A summary of the largest trials on midterm results of anatomic repair is presented in the Table. Early and midterm outcomes of particular surgical techniques are dependent on the complexity of cardiac anatomy and conduction system, presence and hemodynamic significance of associated intracardiac lesions, severity of heart failure, and conditions of the LV before surgery. In most centers, anatomic repair became the surgery of choice for management of ccTGA in the early 1990s. Therefore, large, multicenter, clinical trials describing long-term outcomes have not been published yet. However, results of a few studies with a median follow-up of 5 to 12 years are available. 21, [24] [25] [26] According to these data, several important factors have a major influence on long-term outcomes: late LV dysfunction and failure, occurrence of complete or high-degree heart block and pacemaker implantation, neoaortic valve regurgitation, obstruction of Senning/Mustard pathways, and the need for regular reinterventions if conduits have been used. 26 However, TV function significantly improves after anatomic repair, and direct surgical intervention on the TV is usually not necessary. 27 All investigators confirmed satisfactory late results of double-switch procedures. Survival at 10 to 20 years after surgery was reported as 75% to 85% in the largest series, 21, 25 and freedom from any reintervention varied between 49% and 95%, mostly because of the need for conduit change. Functional outcomes of anatomic repair are also reported as good; >86% of survivors are at New York Heart Association functional class I or II. 21, 23, 25 In addition, anatomic repair has superior results in higher-risk groups (ie, patients with significant TR) compared with physiological repair. 24 Results of the initial studies describing long-term outcomes of the anatomic repair are encouraging, but late morbidity is significant, and well-designed, large, multicenter, clinical trials and meta-analyses are necessary to address all the complex issues and to support this strategy.
PAllIATIVE PRoCEduRES WITh SySTEMIC RV
The strategy of physiological repair includes several surgical approaches to restore normal physiology but does not correct the main anatomic abnormality, the combination of discordant atrioventricular and ventriculo-arterial connections, which leaves the RV as the systemic ventricle. Until the last decade of 20th century, preference was given to this strategy. More recently, anatomic repair has been most commonly applied despite its technical challenges and a wide list of potential contraindications and limitations, the most important of which is the need for a prepared LV. However, elements of physiological repair that treat associated anomalies can be performed in adult and adolescent patients with complex anatomy and therefore remain a valuable option for the management of patients with ccTGA with systemic RVs in the current era.
Correction of Associated Cardiac Anomalies
The repair of associated cardiac anomalies in physiological repair (maintaining systemic RV) comprises closure of the VSD, repair or replacement of the TV (if necessary), and surgical palliations aimed at avoiding morphological LV decompression and septal shift into the LV such as PA banding. Elements of physiological repair can be used in symptomatic children, postpubescent patients, and adult patients with significant associated lesions, but >50% of these patients require delayed surgery or intervention during follow-up. 24 
TV Surgery
TV surgery may be a good option for patients with progressively worsening TR and relatively well-preserved ventricular function. TR leads to volume overload of the systemic RV and exacerbates systemic RV dysfunction. Timely surgical intervention on the TV can interrupt this process and thus improve long-term outcomes. However, TV repair in patients with systemic RV is technically difficult and has suboptimal midterm and long-term results with a high rate of recurrent TR. 28 Exposure to the systemic TV can be challenging, depending on the position of the apex of the heart. The more midline the ventricular mass is, the more rotated the TV is and the harder it is to access the entire valve. In situs inversus (I,D,D), this can be even more challenging. Extensive mobilization of the pericardium and opening the pleural space to allow rotation of the heart can be a useful technique for exposing the valve. In most cases, with the exception of young infants, an annuloplasty ring is required to achieve a more durable repair. Mobilization of a tethered septal and anterior leaflet, particularly at the anteroseptal commissure, is often required in cases in which the septal leaflet is apically displaced or tethered.
TV replacement results in immediate improvement of TV function and can delay or prevent the development of heart failure in adult patients with ccTGA. However, early and late mortality after TV replacement is substantial. 29 Moreover, valve replacement can be performed mainly after adolescence, when the tricuspid annulus has reached adult size and the patient will not outgrow the prosthesis. Despite the fact that the regurgitation is eliminated, patients with TV replacement have the worst outcome among patients with ccTGA because of progressive heart failure. 30 RV function has a great influence on the outcome of this procedure. In a trial from the Mayo Clinic, preoperative RV ejection fraction <40% and morphological LV systolic pressure >50 mm Hg (caused by significant pulmonary outflow tract obstruction or pulmonary hypertension) were identified as the most significant predictors of late RV failure, mortality, or need for cardiac transplantation after TV replacement. 31 It is important to note that successful TV repair or replacement prevents the progression of RV dysfunction in most patients and improves New York Heart Association functional class, but in most cases, it may not improve preexistent RV failure significantly. 11 Therefore, this type of surgery should be performed early to preserve the systemic RV function. Permanent and significant progression of TR is a key indication for TV repair or replacement, even if the regurgitation itself does not seem to be severe at the time of surgery. Patients with atrial fibrillation and pulmonary outflow tract obstruction resulting in high pressures in the morphological LV should be closely assessed before surgery, and simultaneous procedures may be performed to achieve favorable results.
AlTERnATIVE And PRoSPECTIVE oPTIonS In MAnAGEMEnT oF SEVERE RV dySFunCTIon AFTER AdolESCEnCE
Adult patients with systemic RV in biventricular circulation and objective signs of even mild but progressing RV dysfunction or TR have a poor long-term prognosis. Stage of heart failure, degree of TR, and incidence of life-treating arrhythmias inevitably increase in these patients. Heart transplantation is the only radical lifesaving option for adult patients with ccTGA with advanced systemic RV dysfunction. However, this option is not always available for patients with ccTGA. Even if the patient is listed for heart transplantation, survival until donor heart availability requires careful medical management and often interim interventions. Therefore, several alternative palliative surgical options have been used to delay the progression of heart failure, to improve the functional status of these patients, or to provide bridge to transplantation ( Figure 2 ).
high-degree heart Block and Pacer Choice
If advanced second-or third-degree atrioventricular block is present, pacemaker implantation may be necessary. However, late-onset systemic ventricular dysfunction is the most common complication after pacer insertion. A recent trial from our institution described intermediate (median follow-up, 3.7 years) results after pacemaker implantation in 53 pediatric and adult patients with ccTGA. 32 Thirteen pacemaker recipients (26%) had systemic RVs: 9 patients underwent pacer insertion at the time of preparing for anatomic repair, and 4 patients with systemic RVs developed spontaneous heart block. Univentricular pacing was performed in 42 patients, and 22 of them developed significant late-onset systemic ventricular failure. Subsequently, 17 of these patients were upgraded to a biventricular system in an effort to achieve resynchronization, and 7 demonstrated improved systemic ventricular function. It is important to note that none of the 11 patients with primarily inserted biventricular pacemaker system had signs of systemic ventricular failure at the latest follow-up. On the basis of these data, we recommend that strong consideration be given to primary biventricular pacing in all patients with ccTGA who develop heart block.
Cardiac Resynchronization Therapy
Cardiac resynchronization therapy (CRT) has been shown to be an effective potential option in the treatment of patients with systemic RV dysfunction. 9, 33 Ventricular dyssynchrony is not uncommon for ccTGA, particularly those requiring pacing resulting from permanent complete heart block, and a significant percent of patients may benefit from its correction. In a study of 49 adult patients with ccTGA with systemic RV, Diller et al 33 found a significant interventricular conduction delay (QRS >120 milliseconds) in 37% of patients. Jauvert et al 9 applied CRT by a combined transvenous and epicardial approach in 7 symptomatic patients with a systemic RV. All patients had ventricular dyssynchrony caused by delayed septal wall contraction; therefore, the septum and RV free wall were stimulated synchronously, with the goal of resynchronizing a maximum amount of myocardium. Significant improvement in RV mechanical function and clinical and functional status was seen in all cases. The largest multicenter, clinical trial on the application of CRT in patients with a systemic RV was reported by the Dubin et al. 34 CRT was applied in 17 patients (13 patients with ccTGA and 4 with atrium-level correction of simple transposition of the great arteries [Senning or Mustard procedures]). A significant decrease in QRS duration, increase in systemic RV ejection fraction, and clinical improvement was observed in 13 patients. However, the number of patients in this trial is still small, and whether CRT will have similar results in larger groups of patients with ccTGA remains unknown. CRT, however, can be a valuable option for the management of patients with systemic RVs and documented ventricular dyssynchrony, but further application in large groups is necessary to confirm its effectiveness.
Mechanical Circulatory Support
Implantation of a ventricular assist device (VAD) into a systemic RV in ccTGA has been described in several reports limited to small groups or single patients. [35] [36] [37] This approach is typically aimed at a bridge for transplantation rather than at treatment of heart failure with subsequent explantation of the device. VADs have 2 significant advantages for patients with ccTGA over other interim procedures as a bridge to transplantation: They effectively decompress the systemic RV and postpone further development of noncardiac symptoms of heart failure, and they are not dependent on TV function, so patients with severe TR may benefit from their implantation. Implantation of microaxial VADs compensates for the systemic RV failure, improves the patient's quality of life, and reduces the incidence of abdominal wound dehiscence; thus, the patient has a better chance for VAD explantation. 36, 37 Implantation of a VAD into a morphological RV presents a surgical challenge because the inflow cannula of the device can be obstructed by the moderator band. Therefore, it should be placed more posteriorly to avoid this problem. In 2013, Shah et al 37 reported the largest series of VAD implantation in patients with systemic RVs. Six adult patients with systemic RVs (3 patients with ccTGA) underwent implantation of a VAD into the systemic RV. There was 1 early in-hospital death; 1 patient underwent heart transplantation; and the others were either waiting for heart transplantation or listed for destination therapy. The longest period of VAD support was reported as 988 days in this trial.
PhARMAColoGICAl MAnAGEMEnT oF SySTEMIC RV FAIluRE And lIFESTylE
Medical management of congestive systemic RV failure is focused on the prevention of the progression of systemic ventricular dysfunction. Basic principles of pharmacological management do not differ much from the management of congestive LV failure. Aggressive reduction of the preload and afterload of the systemic ventricle and an improvement in ventricular contraction are the main aims of pharmacological treatment.
• Angiotensin-converting enzyme inhibitors and diuretics (spironolactone, furosemide) are typically used for preload and afterload reduction. • Administration of β-blockers (carvedilol, atenolol) is also beneficial in ccTGA but requires close 
PREGnAnCy In WoMEn WITh CCTGA
The latest clinical data demonstrated that most women with ccTGA can successfully carry a pregnancy to term. Kowalik and colleagues 38 reported outcomes of 20 pregnancies in 13 women (median follow-up, 19±15 years). Nineteen pregnancies (95%) were successful, and there were no related maternal deaths. One patient required premature delivery because of deterioration of RV function; supraventricular arrhythmias occurred in 2 women during pregnancy; and 1 patient required temporary pacing for preexistent heart block. Thus, β-blockers and cardiac glycosides should be used with extreme caution in pregnant patients with ccTGA. The rates of hospitalization for heart failure and echocardiographic parameters did not differ much between pregnant and nonpregnant women at the latest follow-up. Preconception counseling and regular follow-up during pregnancy are recommended for women with ccTGA.
ConCluSIonS
Progressive systemic RV dysfunction in patients with ccTGA presents a serious challenge for clinical diagnostics and management. Ventricular dysfunction can progress subclinically during a long period of time and then result in a rapid and unexpected development of congestive heart failure. Therefore, regular, thorough assessment of cardiac function is necessary for timely and correct decisions. Anatomic correction provides good outcomes in very challenging cases and remains a preferable and prospective strategy for the management of ccTGA in the pediatric population. Despite the complexity of the procedure, potential complications, and need for further surveillance, the long-term results indicate a superior late outcome. Adult patients with clinical evidence of advanced progressive congestive heart failure or severe TR present the major challenge. Anatomic repair strategies are not applicable for most of these patients. Alternative surgical options may improve systemic RV function for some time but cannot stop the progression of heart failure. Heart transplantation remains the only lifesaving option for these very sick patients. New solutions for this serious problem will probably come from clinical and laboratory studies. Novel strategies of management will be supported by new types of surgical devices, interventional techniques, and medical therapies.
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